![Mihir Munsif](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mihir Munsif
Corporate Officer/Principal at LipoMedics, Inc.
Network origin in Mihir Munsif first degree
Entity | Entity type | Industry | |
---|---|---|---|
LipoMedics, Inc.
![]() LipoMedics, Inc. Pharmaceuticals: MajorHealth Technology LipoMedics, Inc. develops personalized paclitaxel therapy based on its proprietary Therapeutic Drug Monitoring (TDM) device and its platform for delivery of water insoluble drugs including paclitaxel. The company is headquartered in Fort Worth, TX.
2
| Private Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mihir Munsif via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
University of Oklahoma | College/University | Doctorate Degree | |
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Association for Cancer Research
![]() American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Endocrine Society | Corporate Officer/Principal | ||
SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cenomed, Inc. | Director/Board Member | ||
IgDraSol, Inc.
![]() IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Stocosil, Inc.
![]() Stocosil, Inc. Pharmaceuticals: MajorHealth Technology Stocosil, Inc. operates as a pharmaceutical company which develops, manufactures and markets drug therapies. The firm delivers next generation products that treat the double-threat of hypertension and high cholesterol. The company was founded in December 2014 and is headquartered in City of Industry, CA. | Pharmaceuticals: Major | President | |
Oncotelic, Inc.
![]() Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Biotechnology | Chief Executive Officer | |
IthenaPharma, Inc.
![]() IthenaPharma, Inc. Miscellaneous Commercial ServicesCommercial Services IthenaPharma, Inc. engages in the development and commercialization of combination products for pain, arthritis, hypertension, and cancer. The company was founded on September 30, 2014 and is headquartered in Fountain Valley, CA. | Miscellaneous Commercial Services | Chairman | |
ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Autotelic, Inc.
![]() Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Autotelic, Inc. manufactures therapeutics drugs. Its Therapeutic Drug Monitoring (TDM) device which allows PK guided dosing, reducing the toxicity from overmedication and increasing the efficacy from under-medication. The company was founded in 2013 and is headquartered in Costa Mesa, CA. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
United States | 16 |
Sectoral
Health Technology | 9 |
Commercial Services | 3 |
Consumer Services | 2 |
Health Services | 2 |
Operational
Chief Executive Officer | 7 |
Chairman | 7 |
Corporate Officer/Principal | 5 |
Director/Board Member | 4 |
President | 3 |
Most connected contacts
Insiders | |
---|---|
Vuong Trieu | 16 |
Tapas K. De | 1 |
- Stock Market
- Insiders
- Mihir Munsif
- Company connections